Trading is a hard game but for those with a longer take, the company is arguably at the best position its ever been with 2 defined, parallel growth tracks, FDA approval for consumables (which also adds credibility to OEMs), a partner in a high value segment (vs Labcon commodity focus) and a low market cap which is 35 lower than a year ago. In a market with no sense of value left, BCT is entering 2022 in a much stronger footing than before. But volatility will remain.
Trading is a hard game but for those with a longer take, the...
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.705M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $6.449K | 924.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2870001 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 267941 | 1 |
View Market Depth
| Last trade - 15.05pm 03/05/2024 (20 minute delay) ? |
| BCT (ASX) Chart |